RA
ARA

Royce & Associates’s American Renal Associates Holdings, Inc ARA Stock Holding History

Royce & Associates’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,671
Closed -$35K – 1203
2019
Q2 		$35K Buy
+4,671
New +$30.8K ﹤0.01% 1068
2017
Q4 		– Sell
-685
Closed -$10K – 1287
2017
Q3 		$10K Buy
+685
New +$10.8K ﹤0.01% 1170

Other funds holding ARA

CP
Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royce & Associates's ARA Position: Q3 2019 in Review

Royce & Associates sold out of American Renal Associates Holdings, Inc (ARA) in Q3 2019, closing a stake of 4,671 shares — an estimated $35K sold.

Royce & Associates first reported a position in ARA in Q3 2017 and held it in 2 quarters. The position peaked at $35K in Q2 2019. 63 funds tracked by Wall St. Rank hold ARA as of Q3 2019.

  • Royce & Associates reported no remaining American Renal Associates Holdings, Inc position as of Q3 2019 after selling out during the quarter.
  • Royce & Associates sold 4,671 American Renal Associates Holdings, Inc shares in Q3 2019, an estimated $35K.
  • Royce & Associates first reported a position in American Renal Associates Holdings, Inc in Q3 2017 and held it in 2 quarters.
  • Royce & Associates's American Renal Associates Holdings, Inc position peaked at $35K in Q2 2019.
  • 63 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2019.

Based on Royce & Associates's 13F filing for Q3 2019, filed 13 Nov 2019.